Cargando…

Dual GIPR and GLP-1R agonist tirzepatide inhibits aeroallergen-induced allergic airway inflammation in mouse model of obese asthma

Detalles Bibliográficos
Autores principales:	Toki, Shinji, Zhang, Jian, Printz, Richard L., Newcomb, Dawn C., Cahill, Katherine N., Niswender, Kevin D., Peebles, R. Stokes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163938/ https://www.ncbi.nlm.nih.gov/pubmed/36377605 http://dx.doi.org/10.1111/cea.14252

Ejemplares similares

Glucagon‐like peptide‐1 receptor agonist inhibits aeroallergen‐induced activation of ILC2 and neutrophilic airway inflammation in obese mice
por: Toki, Shinji, et al.
Publicado: (2021)

Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
por: Wang, Lijing
Publicado: (2022)

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets
por: El, Kimberley, et al.
Publicado: (2023)

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
por: Willard, Francis S., et al.
Publicado: (2020)

Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
por: Urva, Shweta, et al.
Publicado: (2021)

Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
por: Urva, Shweta, et al.
Publicado: (2022)

Reagents and models for detecting endogenous GLP1R and GIPR
por: Ast, Julia, et al.
Publicado: (2021)

Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
por: Gallwitz, Baptist
Publicado: (2022)

Prostaglandin I2 inhibits IL-33-induced IL-5 and IL-13 production by human type 2 innate lymphoid cells
por: Zhou, Weisong, et al.
Publicado: (2015)

Fungal Aeroallergen Sensitization Patterns among Airway-Allergic Patients in Zagazig, Egypt
por: Mokhtar, Ghada A., et al.
Publicado: (2023)

The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
por: Min, Thinzar, et al.
Publicado: (2020)

Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes
por: Kaneko, Shizuka
Publicado: (2022)

Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract
por: Morrow, Nadya M., et al.
Publicado: (2021)

Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells
por: Manchanda, Yusman, et al.
Publicado: (2023)

Neural regulation of ILC2s in allergic airway inflammation
por: Thomas, Christopher M., et al.
Publicado: (2023)

Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
por: Killion, Elizabeth A., et al.
Publicado: (2020)

Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
por: Hartman, Mark L., et al.
Publicado: (2020)

Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes
por: Thomas, Melissa K, et al.
Publicado: (2020)

Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
por: Karagiannis, Thomas, et al.
Publicado: (2022)

A systematic review of the safety of tirzepatide-a new dual GLP1 and GIP agonist - is its safety profile acceptable?
por: Meng, Zhuqing, et al.
Publicado: (2023)

FRI078 Real-World Weight Loss Outcomes And Safety Of Tirzepatide, A Novel Dual GIP And GLP-1 Receptor Agonist
por: Fansa, Sima, et al.
Publicado: (2023)

The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation
por: Toki, Shinji, et al.
Publicado: (2016)

Aeroallergens, Allergic Disease, and Climate Change: Impacts and Adaptation
por: Reid, Colleen E., et al.
Publicado: (2009)

The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 (GLP‐1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long‐acting GLP‐1 receptor agonists
por: Urva, Shweta, et al.
Publicado: (2020)

GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys
por: Lu, Shu-Chen, et al.
Publicado: (2021)

Use of Sublingual Immunotherapy for Aeroallergens in Children with Asthma
por: Caffarelli, Carlo, et al.
Publicado: (2020)

TSLP and IL‐33 reciprocally promote each other's lung protein expression and ILC2 receptor expression to enhance innate type‐2 airway inflammation
por: Toki, Shinji, et al.
Publicado: (2020)

Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant
por: Yammine, Lucie, et al.
Publicado: (2023)

Adaptation to Impacts of Climate Change on Aeroallergens and Allergic Respiratory Diseases
por: Beggs, Paul J.
Publicado: (2010)

Characterization of aeroallergen sensitivities in children with allergic rhinitis and chronic rhinosinusitis
por: Sedaghat, Ahmad R., et al.
Publicado: (2014)

Report of Common Aeroallergens among Allergic Patients in Northeastern Iran
por: Mahboubi Oskouei, Yaghoub, et al.
Publicado: (2017)

Prevalence of Aeroallergens in Allergic Rhinitis in a Tertiary Care Hospital
por: Pokharel, Monika, et al.
Publicado: (2020)

Profile of aeroallergen sensitizations in allergic patients living in southern Vietnam
por: Trinh, Tu HK, et al.
Publicado: (2023)

Trends of sensitization to aeroallergens in patients with allergic rhinitis and asthma in the city of Bursa, South Marmara Sea Region of Turkey
por: EDİGER, Dane, et al.
Publicado: (2020)

Gipr Is Essential for Adrenocortical Steroidogenesis; However, Corticosterone Deficiency Does Not Mediate the Favorable Metabolic Phenotype of Gipr(−/−) Mice
por: Bates, Holly E., et al.
Publicado: (2012)

The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
por: Fisman, Enrique Z., et al.
Publicado: (2021)

Efficacy and safety of novel twincretin tirzepatide a dual GIP and GLP-1 receptor agonist in the management of type-2 diabetes: A Cochrane meta-analysis
por: Dutta, Deep, et al.
Publicado: (2021)

Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors
por: Zhao, Fenghui, et al.
Publicado: (2022)

Evaluation of the concentration of the coat of dogs aeroallergens (Canis lupus familiaris) and the dust from families of children with asthma and or allergic rhinitis
por: De Farias, Marconi Rodrigues, et al.
Publicado: (2015)

Large‐scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma
por: Smith, Alisha M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_le0o266v8lruv4ni3vc9gqrg7k